Stocktoria

ZeroStack Corp. ZSTK

Nasdaq · XNAS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Chart by TradingView
0/9
Piotroski F — financial health
-13.69
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$35.7M$35.9M$76.1M$33.4M$9.0M
Gross profit$1.6M$2.2M$17.7M$13.3M$2.4M
Operating income-$154.7M-$8.9M-$50.4M-$47.2M-$19.0M
Net income-$15.9M-$57.0M-$52.4M-$21.4M
Operating cash flow-$8.7M-$5.0M-$8.4M-$15.9M-$20.9M
Free cash flow-$8.8M-$5.2M-$8.6M-$17.2M-$24.9M
Total assets$130.2M$26.2M$23.6M$81.0M$85.5M
Total liabilities$59.7M$21.7M$17.2M$24.6M$8.5M
Shareholders' equity$70.6M$4.5M$6.4M$56.4M$76.9M
Ratios
Gross margin4.6%6.1%23.3%39.7%27.0%
Operating margin-433.5%-24.9%-66.2%-141.4%-211.6%
Net margin-44.4%-75.0%-156.9%-237.9%
FCF margin-24.7%-14.4%-11.3%-51.6%-277.5%
Return on assets-60.7%-241.4%-64.7%-25.0%
Return on equity-352.7%-890.6%-92.9%-27.8%
Debt / equity0.76×0.00×
Current ratio1.011.051.311.797.84
Revenue growth-0.5%-52.9%127.8%271.9%

Why these scores methodology →

Piotroski F-score: 0/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -13.69 (distress)

  • Working capital / assets 0.001
  • Retained earnings / assets -2.133
  • EBIT / assets -1.187
  • Equity / liabilities 1.182

Sector peers

MCK · CAH · SYY · PFGC · SNX · INGM · all Wholesale Trade →

Source: SEC EDGAR filings · CIK 0001790169 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.